Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-α expression in neonatal rat cardiac myocytes

Circulation Research

Volumn 87, Issue 7, 2000, Pages 596-602

  Takano, Hiroyuki ^a   Nagai, Toshio ^a   Asakawa, Masayuki ^a   Toyozaki, Tetsuya ^a   Oka, Toru ^b   Komuro, Issei ^b   Saito, Toshihiro ^a   Masuda, Yoshiaki ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cardiac myocyte; Nuclear factor B; Peroxisome proliferator activated receptor; Tumor necrosis factor

Indexed keywords

COMPLEMENTARY DNA; GEMFIBROZIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; ROSIGLITAZONE; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; IMMUNOCYTOCHEMISTRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0034730794     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.7.596     Document Type: Article

References (35)

1. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction
2. Increased circulating cytokines in patients with myocarditis and cardiomyopathy
3. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
4. Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart
5. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
6. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart
7. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α
8. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α
9. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
10. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-actirated receptors α and δ
11. 2 is a ligand for the adipocyte determination factor PPARγ
12. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators
13. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat
14. Distribution of mRNAs encoding the peroxisome proliferator-activated receptor α, β, and γ and the retinoid X receptor α, β, and γ in rat central nervous system
15. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
16. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
17. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
18. Stretching cardiac myocytes stimulates proto-oncogene expression
19. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells
20. Nuclear factor NF-κB in myocardium: Developmental expression of subunits and activation by interleukin-1β in cardiac myocytes in vitro
21. Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-α
22. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
23. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor a gene in primary macrophages
24. Lipopolysaccharide-induced tumor necrosis factor-α promoter activity is inhibitor of nuclear factor-κB kinase-dependent
25. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia
26. p300 functions as a coactivator for the peroxisome proliferator-activated receptor α
27. The antidiabetic agent thiazolidinedione stimulates the interaction between PPARγ and CBP
28. CREB-binding protein/p300 are transcriptional coactivators of p65
29. Nuclear integration of glucocorticoid receptor and nuclear factor-κB signaling by CREB-binding protein and steroid receptor coactivator-1
30. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator activated receptor γ
31. Regulation of fatty acid oxidation in the mammalian heart in health and disease
32. Subchronic toxicity of the thiazolidinedione, Tanabe-174 (LY282449), in the rat and dog
33. Peroxisome proliferator-activated receptor γ activators inhibit gene expression and migration in human vascular smooth muscle cells
34. PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells
35. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway